Novan (NOVNW) EV-to-EBIT : 0.00 (As of May. 21, 2025)

View and export this data going back to 2018. Start your Free Trial

What is Novan EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Novan's Enterprise Value is $0.00 Mil. Novan's EBIT for the trailing twelve months (TTM) ended in Mar. 2023 was $-30.40 Mil. Therefore, Novan's EV-to-EBIT for today is 0.00.

The historical rank and industry rank for Novan's EV-to-EBIT or its related term are showing as below:

NOVNW' s EV-to-EBIT Range Over the Past 10 Years
Min: -12.64 Med: -1.09 Max: 0.29
Current: 0.29

During the past 9 years, the highest EV-to-EBIT of Novan was 0.29. The lowest was -12.64. And the median was -1.09.

NOVNW's EV-to-EBIT is not ranked
in the Biotechnology industry.
Industry Median: 8.09 vs NOVNW: 0.29

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Novan's Enterprise Value for the quarter that ended in Mar. 2023 was $0.00 Mil. Novan's EBIT for the trailing twelve months (TTM) ended in Mar. 2023 was $-30.40 Mil. Novan's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2023 was %.

Novan EV-to-EBIT Historical Data

The historical data trend for Novan's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Novan EV-to-EBIT Chart

Novan Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

EV-to-EBIT

Get a 7-Day Free Trial

-0.76

-2.54

-3.19

-1.18

-0.93

Novan Quarterly Data
	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23
EV-to-EBIT	Get a 7-Day Free Trial															-1.76	-0.90	-0.99	-0.93	-0.91

Competitive Comparison of Novan's EV-to-EBIT

For the Biotechnology subindustry, Novan's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Novan's EV-to-EBIT Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Novan's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Novan's EV-to-EBIT falls into.

Save Embed

;

Save Embed

;

Novan EV-to-EBIT Calculation

Novan's EV-to-EBIT for today is calculated as:

EV-to-EBIT	=	Enterprise Value (Today)	/	EBIT (TTM)
	=	0.000	/	-30.397
	=	0.00

Novan's current Enterprise Value is $0.00 Mil.
Novan's EBIT for the trailing twelve months (TTM) ended in Mar. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-30.40 Mil.

Novan (OTCPK:NOVNW) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Novan's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2023 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Mar. 2023 )	=	EBIT	/	Enterprise Value (Q: Mar. 2023 )
	=	-30.397	/	0
	=	%

Novan's Enterprise Value for the quarter that ended in Mar. 2023 was $0.00 Mil.
Novan's EBIT for the trailing twelve months (TTM) ended in Mar. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-30.40 Mil.

Novan EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Novan's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

Novan Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Novan Inc (OTCPK:NOVNW) » Definitions » EV-to-EBIT

Comparable Companies

Traded in Other Exchanges

N/A

Address

P.O. Box 64, Pittsboro, NC, USA, 27312

Website

https://www.novan.com

NVN Liquidation Inc Formerly Novan Inc is a dermatology company focused on developing and commercializing therapeutic products for skin diseases. It is developing SB206 as a topical prescription gel for the treatment of viral skin infections. The company's product portfolio includes; Wynzora Cream for the treatment of plaque psoriasis, Rhofade cream for the treatment of persistent facial erythema, Minolira tablets to treat inflammatory lesions of non-nodular moderate to severe acne vulgaris in patients, Cloderm cream for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses, Sitavig tablets for the treatment of recurrent herpes labialis in immunocompetent adults, and Nuvail nail solution for managing signs and symptoms of nail dystrophy.